Overview
Neonatal thrombocytopenia is prevalent among infants admitted to neonatal intensive care units, particularly in premature infants, often necessitating prophylactic platelet transfusions to mitigate bleeding risks 34.Diagnosis
Management
Special Populations
Key Recommendations
References
1 Keir A, Grace E, Stanworth S. Closing the evidence to practice gap in neonatal transfusion medicine. Seminars in fetal & neonatal medicine 2021. link 2 Bianchi M, Orlando N, Valentini CG, Papacci P, Vento G, Teofili L. Infectious complications in neonatal transfusion: Narrative review and personal contribution. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2020. link 3 Sola-Visner M, Bercovitz RS. Neonatal Platelet Transfusions and Future Areas of Research. Transfusion medicine reviews 2016. link 4 Stanworth SJ. Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates. Hematology. American Society of Hematology. Education Program 2012. link 5 Fung MK, Roseff SD, Vermoch KL. Blood component preferences of transfusion services supporting infant transfusions: a University HealthSystem Consortium benchmarking study. Transfusion 2010. link 6 Dimick C. Complicated game. HISPC privacy and security collaborative hands off three years of work. Journal of AHIMA 2009. link 7 Diamond C, Ricciardi L. Building consumer trust into health information exchange. Journal of AHIMA 2006. link 8 Lasky LC, Lane TA, Miller JP, Lindgren B, Patterson HA, Haley NR et al.. In utero or ex utero cord blood collection: which is better?. Transfusion 2002. link